Grifols (GRFS) Cash & Equivalents (2009 - 2025)
Grifols (GRFS) reported Cash & Equivalents of $960.34 million for the quarter ended Dec 31, 2025, down 8.3% from $1.05 billion a year earlier.
Powered by 
Analysis
Grifols (GRFS) Cash & Equivalents (2009 - 2025) Analysis & Trends
As of Dec 31, 2025, Grifols posted Cash & Equivalents of $932.09 million, down 11.0% from the prior year.
- Cash & Equivalents has a five-year compound annual growth rate of 1.9% (years ended Dec 2020 to Dec 2025).
- By year, Cash & Equivalents came in at $1.05 billion in the year ended Dec 31, 2024 (+84.0%), $569.17 million in the year ended Dec 31, 2023 (+1.6%), $560.12 million in the year ended Dec 31, 2022 and $14.99 million in the year ended Dec 31, 2021 (-98.2%).
- The figure for the quarter ended Dec 31, 2025 ranks as the lowest quarterly Cash & Equivalents since the quarter ended Dec 31, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Grifols | 4.97 Bn | 4.58 Bn | 3.33 Bn | 960.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 960.34 Mn |
| Dec 31, 2024 | 1.05 Bn |
| Dec 31, 2023 | 569.17 Mn |
| Dec 31, 2022 | 560.12 Mn |
| Dec 31, 2021 | 3.06 Bn |
| Dec 31, 2020 | 691.11 Mn |
| Sep 30, 2020 | 1.21 Bn |
| Mar 31, 2020 | 703.98 Mn |
| Dec 31, 2019 | 1.14 Bn |
| Sep 30, 2019 | 881.43 Mn |
| Mar 31, 2019 | 1.18 Bn |
| Dec 31, 2018 | 1.18 Bn |
| Sep 30, 2018 | 676.95 Mn |
| Jun 30, 2018 | 797.82 Mn |
| Mar 31, 2018 | 1.09 Bn |
| Dec 31, 2017 | 1.04 Bn |
| Jun 30, 2017 | 824.90 Mn |
| Mar 31, 2017 | 953.55 Mn |
| Dec 31, 2016 | 966.36 Mn |
| Sep 30, 2016 | 1.01 Bn |
API Access
Grifols Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GRFS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GRFS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GRFS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();